10.50

6.03% -0.75

Kura Oncology Inc (KURA)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Schlusskurs vom Vortag:

$11.25

Offen:

$11.34

24-Stunden-Volumen:

2.12M

Relative Volume:

1.35

Marktkapitalisierung:

$932.13M

Einnahmen:

$67.48M

Nettoeinkommen (Verlust:

$-278.67M

KGV:

-3.3046

EPS:

-3.1774

Netto-Cashflow:

$-70.70M

1W Leistung:

+17.99%

1M Leistung:

+14.17%

6M Leistung:

-11.83%

1J Leistung:

+87.45%

1-Tages-Spanne:

$10.49

$11.43

1-Wochen-Bereich:

$8.98

$11.52

52-Wochen-Spanne:

$5.45

$12.49

Kura Oncology Inc Stock (KURA) Company Profile

Firmenname

Kura Oncology Inc

Sektor

Healthcare (1110)

Branche

Biotechnology (618)

Telefon

(858) 500-8800

Adresse

4930 DIRECTORS PLACE, SUITE 500, SAN DIEGO, CA

Mitarbeiter

260

Twitter

@kuraoncology

Nächster Verdiensttermin

2026-05-12

Neueste SEC-Einreichungen

KURA's Discussions on Twitter

Compare KURA vs VRTX, REGN, ARGX, ALNY, RVMD

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
KURA Kura Oncology Inc	10.50	998.71M	67.48M	-278.67M	-70.70M	-3.1774
VRTX Vertex Pharmaceuticals Inc	436.71	110.28B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	634.47	66.98B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	806.47	50.15B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	295.15	39.71B	4.29B	577.22M	641.34M	4.2086
RVMD Revolution Medicines Inc	154.77	32.22B	742.00K	-1.37B	-1.07B	-7.0731

Kura Oncology Inc Stock (KURA) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2026-04-14	Eingeleitet	Lake Street	Buy
2025-09-04	Eingeleitet	Guggenheim	Neutral
2025-02-06	Herabstufung	BTIG Research	Buy → Neutral
2024-10-24	Eingeleitet	UBS	Buy
2024-10-14	Herabstufung	Stifel	Buy → Hold
2023-12-22	Eingeleitet	Mizuho	Buy
2023-08-11	Eingeleitet	BofA Securities	Buy
2023-07-27	Eingeleitet	Scotiabank	Sector Perform
2023-05-17	Eingeleitet	BTIG Research	Buy
2023-01-31	Eingeleitet	Stifel	Buy
2022-07-12	Eingeleitet	Cantor Fitzgerald	Overweight
2022-02-15	Eingeleitet	Jefferies	Buy
2021-05-05	Fortgesetzt	Credit Suisse	Outperform
2021-04-26	Fortgesetzt	Credit Suisse	Outperform
2020-12-07	Bestätigt	H.C. Wainwright	Buy
2020-12-03	Eingeleitet	Stifel	Buy
2020-11-05	Herabstufung	Piper Sandler	Overweight → Neutral
2020-07-07	Eingeleitet	Credit Suisse	Outperform
2020-05-05	Eingeleitet	Barclays	Overweight
2019-07-18	Eingeleitet	Deutsche Bank	Buy
2018-11-09	Eingeleitet	Piper Jaffray	Overweight
2018-08-01	Eingeleitet	H.C. Wainwright	Buy
2016-10-13	Fortgesetzt	Leerink Partners	Outperform
2016-01-22	Eingeleitet	JMP Securities	Mkt Outperform
2015-12-30	Eingeleitet	Oppenheimer	Outperform
2015-12-16	Eingeleitet	Citigroup	Buy

Alle ansehen

Kura Oncology Inc Aktie (KURA) Neueste Nachrichten

08:11 AM

Kura Oncology reports strong tumor shrinkage with darlifarnib + adagrasib in KRAS G12C-mutated cancers. - Pluang

08:11 AM

07:18 AM

KURA: Promising Results from FIT-001 Trial of Darlifarnib - GuruFocus

07:18 AM

06:17 AM

Kura Oncology reports tumor shrinkage in cancer drug trial - Investing.com

06:17 AM

Kura Oncology reports tumor shrinkage in cancer drug trial By Investing.com - Investing.com Canada

06:17 AM

06:11 AM

Kura Oncology Reports Promising Phase 1 Results for Darlifarnib in Combination with Adagrasib in KRAS G12C-Mutated Tumors - Quiver Quantitative

06:11 AM

06:02 AM

Experimental drug combo shrinks tumors in 77% of advanced cancer patients - Stock Titan

06:02 AM

May 24, 2026

Kura Oncology’s SWOT analysis: biotech stock faces launch test By Investing.com - Investing.com India

May 24, 2026

Kura Oncology’s SWOT analysis: biotech stock faces launch test - Investing.com UK

May 24, 2026

May 22, 2026

KURA (NASDAQ: KURA) files Form 144 reporting proposed sale of 10,000 RSUs - Stock Titan

May 21, 2026

symbol__ Stock Quote Price and Forecast - CNN

May 21, 2026

May 20, 2026

Kura Oncology COO Kathleen Ford sells $20,482 in stock By Investing.com - Investing.com South Africa

May 20, 2026

Insider Sell: Brian Powl Sells Shares of Kura Oncology Inc (KURA) - GuruFocus

May 20, 2026

Kura Oncology COO Kathleen Ford sells $20,482 in stock - Investing.com

May 20, 2026

Kathleen Ford Sells 2,257 Shares of Kura Oncology Inc (KURA) - GuruFocus

May 20, 2026

Kura Oncology (KURA) CCO sells 339 shares while retaining 183,614 - Stock Titan

May 20, 2026

Kura Oncology (KURA) COO sells 2,257 shares under pre-set trading plan - Stock Titan

May 20, 2026

[Form 4] Kura Oncology, Inc. Insider Trading Activity - Stock Titan

May 20, 2026

KURA News | KURA ONCOLOGY INC (NASDAQ:KURA) - ChartMill

May 20, 2026

May 19, 2026

[144] Kura Oncology, Inc. SEC Filing - Stock Titan

May 19, 2026

Kura Oncology to Present at TD Cowen 7th Annual Oncology Innovation Summit - The Manila Times

May 19, 2026

Kura Oncology Q1 earnings call highlights - MSN

May 19, 2026

May 18, 2026

Kura Oncology’s SWOT analysis: stock faces launch challenges despite FDA approval - Investing.com UK

May 18, 2026

Kura Oncology’s SWOT analysis: biotech stock faces launch challenges - Investing.com

May 18, 2026

Kura Oncology’s SWOT analysis: biotech stock faces launch challenges By Investing.com - Investing.com Nigeria

May 18, 2026

Earnings call transcript: Kura Oncology Q1 2026 revenue miss overshadows stable EPS - Investing.com UK

May 18, 2026

May 17, 2026

Some Analysts Just Cut Their Kura Oncology, Inc. (NASDAQ:KURA) Estimates - Yahoo Finance

May 17, 2026

Kura Oncology stock (US50126D1028): FDA breakthrough nod and pipeline update draw investor focus - AD HOC NEWS

May 17, 2026

May 16, 2026

LifeSci Capital Maintains Kura Oncology(KURA.US) With Buy Rating, Maintains Target Price $28 - Moomoo

May 16, 2026

UBS Group AG Acquires 574,455 Shares of Kura Oncology, Inc. $KURA - MarketBeat

May 16, 2026

Kura Oncology (NASDAQ:KURA) Rating Increased to Hold at Wall Street Zen - MarketBeat

May 16, 2026

May 15, 2026